Last reviewed · How we verify
NCT05331352: FEMATAM
Attachment Style and Mentalization Impact Among Women Victims of Domestic Violence
NA trial testing Semi-structured interviews in Violence, Domestic in 30 participants. Status unknown.
30 September 2023
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Besancon |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 October 2020 |
| Primary completion | 30 September 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Semi-structured interviews
- Projective methode
- Selfreported
Conditions studied
- Violence, Domestic — all drugs for Violence, Domestic →
Sponsor
Centre Hospitalier Universitaire de Besancon
Who can join
20 and older, female only, with Violence, Domestic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Attachment and mentalization with a population of domestic violence victims Domestic violence is one of the most common forms of domestic violence. Multiform and complex, it affects all backgrounds and all ages. According to a survey instituted by the government of Emmanuel Macron, 219,000 women were recognized as victims of domestic violence in 2017. This phenomenon is not without questioning the scientific scene. Also, this study focus on the quality of the attachment because if this bond is insecure, it can constitute a point of vulnerability in self-construction and impact on future relational modalities.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05331352
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Semi-structured interviews
Trials testing the same drug.
- NCT07132710 — Reorganization Strategy to Optimize the Use of Virtual Reality · active not recruiting
- NCT06664333 — Experiences Reported by Siblings of Children Hospitalized in the PICU · recruiting
- NCT06621290 — Patient Experience of CFS-assessment in the ED · completed
- NCT06211673 — Psychiatric Phenotype Characterization of Individuals With FOXP1 Syndrome · completed
- NCT06035549 — Resilience in East Asian Immigrants for Advance Care Planning Discussions · recruiting
Other recruiting trials for Violence, Domestic
Currently open trials in the same condition.
- NCT06650267 — Substance Misuse and Family Violence Treatment Fathers · Phase 2 · recruiting
- NCT05768217 — Community Resiliency Collective Efficacy Intervention · NA · recruiting
- NCT04235335 — Healing Circles: An Intervention for Canadian Indigenous Mothers & Children Affected by IPV · NA · recruiting
Other Centre Hospitalier Universitaire de Besancon trials
Trials by the same sponsor.
- NCT07492199 — High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear. · not yet recruiting
- NCT07438015 — VEXUS-REA : Evaluation of Ultrasound Parameters of Venous Congestion in Patients in a Medical Intensive Care Unit · NA · not yet recruiting
- NCT06796114 — Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Du · NA · recruiting
- NCT06864065 — Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder · NA · recruiting
- NCT07067762 — Botulinum Toxin Injections Into the Salivary Glands of Cerebrospinal Children With Chronic Sialorrhea · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05331352 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Besancon
- Last refreshed: 15 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05331352.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing